3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
5
Terminated
2
Recruiting
2
Unknown
1
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Venous Thrombosis
3
Neoplasms
3
Venous Thromboembolism
2
Thrombosis
1
Soft Tissue Neoplasms
1
Pulmonary Embolism
1
Pancreatic Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Catheter-Related Infections
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dalteparin
5
Tinzaparin
4
apixaban
2
abelacimab
2
Nadroparin
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Enoxaparin
2
reviparin
1
certoparin
1
bemiparin
1
acarboxyprothrombin
1
Warfarin
1
Rivaroxaban
1
Platelet Transfusion
1
Phenprocoumon
1
Mass Screening
1
Hematologic Tests
1
Aspirin
1
Acenocoumarol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Venous Thromboembolism
×
Enoxaparin
×
Clear all
NCT01817257
2018-10-29
ALICAT
Cardiff University
Phase 2
Terminated
2 enrolled
NCT01164046
2014-12-03
Longheva
University Medical Center Groningen
Phase 3
Terminated
56 enrolled